Literature DB >> 11072076

Regulation of SRp20 exon 4 splicing.

H Jumaa1, P J Nielsen.   

Abstract

SR proteins are essential splicing factors involved in the use of both constitutive and alternative exons. We previously showed that the SR proteins SRp20 and ASF/SF2 have antagonistic activities on SRp20 pre-mRNA splicing. SRp20 activates exon 4 recognition in its pre-mRNA, whereas ASF/SF2 inhibits this recognition. In experiments aimed at testing the specificity of SRp20 and ASF/SF2 for exon 4 splicing regulation, we show here that this specificity lies in the RNA binding domains of SRp20 and ASF/SF2 and not in the RS domains. Surprisingly, a deletion of 14 amino acids at the end of ASF/SF2-RBD2 converts ASF/SF2 from an inhibitor to an activator of exon 4 splicing. We found that ASF3 also inhibits exon 4 recognition, thus acting similarly to ASF/SF2, while SC35 activates a cryptic 5' splice site downstream of exon 3 and, in doing so, represses exon 4 use. In contrast, Tra2 and the SR proteins 9G8 and SRp40 do not appear to affect exon 4 splicing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072076     DOI: 10.1016/s0167-4781(00)00233-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice.

Authors:  Supriya Sen; Magda Langiewicz; Hassan Jumaa; Nicholas J G Webster
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

2.  Degradation of splicing factor SRSF3 contributes to progressive liver disease.

Authors:  Deepak Kumar; Manasi Das; Consuelo Sauceda; Lesley G Ellies; Karina Kuo; Purva Parwal; Mehak Kaur; Lily Jih; Gautam K Bandyopadhyay; Douglas Burton; Rohit Loomba; Olivia Osborn; Nicholas Jg Webster
Journal:  J Clin Invest       Date:  2019-08-08       Impact factor: 14.808

3.  Construction and evaluation of an adenoviral vector for the liver-specific expression of the serine/arginine-rich splicing factor, SRSF3.

Authors:  Amanda L Suchanek; Lisa M Salati
Journal:  Plasmid       Date:  2015-08-01       Impact factor: 3.466

4.  Molecular basis of RNA recognition and TAP binding by the SR proteins SRp20 and 9G8.

Authors:  Yann Hargous; Guillaume M Hautbergue; Aura M Tintaru; Lenka Skrisovska; Alexander P Golovanov; James Stevenin; Lu-Yun Lian; Stuart A Wilson; Frédéric H-T Allain
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

5.  Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer.

Authors:  X He; A D Arslan; M D Pool; T-T Ho; K M Darcy; J S Coon; W T Beck
Journal:  Oncogene       Date:  2010-09-20       Impact factor: 9.867

6.  Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAs.

Authors:  M Andrea Markus; Francine Z Marques; Brian J Morris
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

7.  XE7: a novel splicing factor that interacts with ASF/SF2 and ZNF265.

Authors:  A Helena Mangs; Helen J L Speirs; Christine Goy; David J Adams; M Andrea Markus; Brian J Morris
Journal:  Nucleic Acids Res       Date:  2006-09-18       Impact factor: 16.971

8.  PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.

Authors:  Jihua Guo; Jun Jia; Rong Jia
Journal:  Sci Rep       Date:  2015-09-29       Impact factor: 4.379

9.  Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.

Authors:  Xiaolong He; Pei Zhang
Journal:  Mol Cancer       Date:  2015-08-19       Impact factor: 27.401

10.  SRSF3 recruits DROSHA to the basal junction of primary microRNAs.

Authors:  Kijun Kim; Trung Duc Nguyen; Shaohua Li; Tuan Anh Nguyen
Journal:  RNA       Date:  2018-04-03       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.